Skip to contentT
Thermo Fisher Scientific Inc.
T
TMOThermo Fisher Scientific Inc. Q2 2022 · 10-Q
Revenue$10.97B$10.97B+18.3% vs Q2 2021 Net Income$1.67B$1.67B−8.8% vs Q2 2021 EPS Diluted$4.22$4.22−8.5% vs Q2 2021 Operating Income$2,001,000,000−7.5% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Thermo Fisher Scientific Inc. · CIK 97745 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$1,022,000,000−39.4% Margins · derivedOperating margin18.2%−5.1 pt vs Q2 2021
Net margin15.2%−4.5 pt vs Q2 2021
ended Jul 2, 2022 · filed Aug 5, 2022 · 34 d after period end